Equities
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Key statistics

On Monday, AstraZeneca PLC (AZN:NSQ) closed at 66.74, -7.46% below its 52-week high of 72.12, set on Jan 10, 2023.
52-week range
Today
52.65Sep 26 202272.12Jan 10 2023
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open65.92
High66.77
Low65.79
Bid66.50
Offer66.66
Previous close65.61
Average volume4.63m
Shares outstanding3.10bn
Free float2.99bn
P/E (TTM)62.26
Market cap202.91bn USD
EPS (TTM)1.05
USD
Annual div (ADY)2.44
USD
Annual div yield (ADY)3.71%
Div ex-dateFeb 23 2023
Div pay-dateMar 27 2023
Data delayed at least 15 minutes, as of Mar 20 2023 20:00 BST.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.